Case Study:
Using AI in Precision Identification of Patients With Rare Diseases
AI-Powered Rare Disease Patient Identification and Diagnosis
Rare diseases offer diverse challenges. With Pharma offering rare disease medication, if you can find the patient, they will take your drug; however, finding the patient is the tricky part.
The Client Problem
The client had a rare disease drug with minimal competition.
• The illness is so rare, however, that the main difficulty was finding patients.
• Very few physicians were likely to come in contact with these patients.
• Finding these patients early is critical as the illness progresses.
The Solution
• Certain facial traits were common to sufferers of the condition.
• Eularis created facial recognition software that identified patients with the condition
• It then crawled internet properties, (Facebook and Flickr etc), to find patients from online photos
• This allowed for faster identification and treatment before it was too late for these patients.
• However, due to sensitivity, the identification was addressed in a more palatable way.
• Once patients were identified, targeted advertising of keywords on Google PPC was prepared.
• Therefore, only when a search was conducted on the symptoms by the family, would this be activiated
• This triggered an ad leading them to our client’s website where they could self diagnose
The Outcome
Thirteen new patients were identified very rapidly. At a cost of $500,000/patient/year for the rest of their life, the ROI is undeniable.
To achieve these kinds of results, contact Eularis today.

Latest News
Read our latest blogs here.

How Artificial Intelligence revolutionizes the management of Rare Diseases
Rare diseases develop complex problems in healthcare systems. The world’s 7,000-8,000 rare diseases collectively affect more than 300 million people globally although each disease affects

How to Overcome AI Resistance in Your Organization
In the crucible of modern drug development—where a single molecule’s journey from lab to patient spans an average of 12 years and $2.3 billion—AI has emerged

CRO 2.0: Transforming Tomorrow’s Clinical Research Process with Artificial Intelligence
The clinical trial ecosystem—a $90 billion engine driving medical innovation—is struggling under the burden of its own complexity. Despite significant advancements in therapeutic science, a